vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and NATURAL RESOURCE PARTNERS LP (NRP). Click either name above to swap in a different company.

NATURAL RESOURCE PARTNERS LP is the larger business by last-quarter revenue ($51.3M vs $45.1M, roughly 1.1× Amarin Corp plc). NATURAL RESOURCE PARTNERS LP runs the higher net margin — 78.5% vs -23.3%, a 101.8% gap on every dollar of revenue. On growth, Amarin Corp plc posted the faster year-over-year revenue change (7.0% vs -21.8%). Over the past eight quarters, NATURAL RESOURCE PARTNERS LP's revenue compounded faster (-8.3% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Natural Resource Partners LP is a U.S.-headquartered master limited partnership that owns, manages and leases mineral reserve interests. Its asset portfolio covers coal, aggregates, industrial minerals and oil & gas, with operations primarily across North America, deriving most revenue from royalties paid by third-party resource extraction operators.

AMRN vs NRP — Head-to-Head

Bigger by revenue
NRP
NRP
1.1× larger
NRP
$51.3M
$45.1M
AMRN
Growing faster (revenue YoY)
AMRN
AMRN
+28.8% gap
AMRN
7.0%
-21.8%
NRP
Higher net margin
NRP
NRP
101.8% more per $
NRP
78.5%
-23.3%
AMRN
Faster 2-yr revenue CAGR
NRP
NRP
Annualised
NRP
-8.3%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q1 FY2025

Metric
AMRN
AMRN
NRP
NRP
Revenue
$45.1M
$51.3M
Net Profit
$-10.5M
$40.3M
Gross Margin
Operating Margin
35.5%
83.7%
Net Margin
-23.3%
78.5%
Revenue YoY
7.0%
-21.8%
Net Profit YoY
33.0%
-28.4%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
NRP
NRP
Q1 26
$45.1M
Q4 25
$49.2M
Q3 25
$49.7M
Q2 25
$72.7M
Q1 25
$42.0M
$51.3M
Q4 24
$62.3M
$61.8M
Q3 24
$42.3M
$50.4M
Q2 24
$67.5M
$54.6M
Net Profit
AMRN
AMRN
NRP
NRP
Q1 26
$-10.5M
Q4 25
$-1.2M
Q3 25
$-7.7M
Q2 25
$-14.1M
Q1 25
$-15.7M
$40.3M
Q4 24
$-48.6M
$42.8M
Q3 24
$-25.1M
$38.6M
Q2 24
$1.5M
$46.1M
Gross Margin
AMRN
AMRN
NRP
NRP
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
Q2 24
63.4%
Operating Margin
AMRN
AMRN
NRP
NRP
Q1 26
35.5%
Q4 25
-12.9%
Q3 25
-22.4%
Q2 25
-22.0%
Q1 25
-39.9%
83.7%
Q4 24
-84.3%
74.9%
Q3 24
-59.5%
84.9%
Q2 24
-0.8%
92.3%
Net Margin
AMRN
AMRN
NRP
NRP
Q1 26
-23.3%
Q4 25
-2.5%
Q3 25
-15.6%
Q2 25
-19.4%
Q1 25
-37.4%
78.5%
Q4 24
-78.0%
69.2%
Q3 24
-59.4%
76.6%
Q2 24
2.3%
84.4%
EPS (diluted)
AMRN
AMRN
NRP
NRP
Q1 26
Q4 25
$0.00
Q3 25
$-0.02
Q2 25
$-0.03
Q1 25
$-0.04
Q4 24
$-0.12
Q3 24
$-0.06
Q2 24
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
NRP
NRP
Cash + ST InvestmentsLiquidity on hand
$307.8M
$30.9M
Total DebtLower is stronger
$138.8M
Stockholders' EquityBook value
Total Assets
$645.8M
$772.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
NRP
NRP
Q1 26
$307.8M
Q4 25
$302.6M
Q3 25
$286.6M
Q2 25
$298.7M
Q1 25
$281.8M
$30.9M
Q4 24
$294.2M
$30.4M
Q3 24
$305.7M
$30.9M
Q2 24
$306.7M
$32.3M
Total Debt
AMRN
AMRN
NRP
NRP
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
$138.8M
Q4 24
$142.1M
Q3 24
$197.4M
Q2 24
$210.3M
Stockholders' Equity
AMRN
AMRN
NRP
NRP
Q1 26
Q4 25
$459.3M
Q3 25
$458.9M
Q2 25
$464.9M
Q1 25
$473.7M
Q4 24
$486.2M
Q3 24
$531.4M
Q2 24
$551.9M
Total Assets
AMRN
AMRN
NRP
NRP
Q1 26
$645.8M
Q4 25
$670.8M
Q3 25
$659.8M
Q2 25
$670.1M
Q1 25
$655.7M
$772.5M
Q4 24
$685.3M
$772.9M
Q3 24
$750.6M
$772.9M
Q2 24
$799.9M
$789.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
NRP
NRP
Operating Cash FlowLast quarter
$34.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.86×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
NRP
NRP
Q1 26
Q4 25
$15.3M
Q3 25
$-12.7M
Q2 25
$16.6M
Q1 25
$-12.5M
$34.4M
Q4 24
$-13.3M
$66.2M
Q3 24
$-2.4M
$54.1M
Q2 24
$-2.7M
$56.6M
Capex Intensity
AMRN
AMRN
NRP
NRP
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Cash Conversion
AMRN
AMRN
NRP
NRP
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
0.86×
Q4 24
1.55×
Q3 24
1.40×
Q2 24
-1.81×
1.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

NRP
NRP

Coal Royalty Revenues$35.5M69%
Soda Ash Segment$4.6M9%
Transportation And Processing Services$4.4M9%
Production Lease Minimum Revenues$2.7M5%
Oil And Gas Royalty Revenues$2.4M5%
Other$1.6M3%

Related Comparisons